UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Target Hospitality
TH
$1.64B
| $542K | ﹤0.01% |
41,285
| – | – |
|
2227
V2X
VVX
$2.65B
| $540K | ﹤0.01% |
13,599
-6,944
| -34% | -$297K |
|
2228
AngioDynamics
ANGO
$649M
| $537K | ﹤0.01% |
51,951
+4,011
| +8% | +$51.3K |
|
|
ROCC
2229
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $536K | ﹤0.01% |
13,119
-964
| -7% | -$39.5K |
|
2230
Insteel Industries
IIIN
$625M
| $535K | ﹤0.01% |
19,241
+2,369
| +14% | +$68.9K |
|
2231
OrthoPediatrics
KIDS
$595M
| $535K | ﹤0.01% |
12,075
+6,775
| +128% | +$299K |
|
2232
Fluence Energy
FLNC
$2.44B
| $535K | ﹤0.01% |
26,400
+1,600
| +6% | +$31.8K |
|
2233
Seres Therapeutics
MCRB
$48.9M
| $534K | ﹤0.01% |
4,705
+587
| +14% | +$63.5K |
|
2234
Brookdale Senior Living
BKD
$3.4B
| $533K | ﹤0.01% |
180,733
-30,322
| -14% | -$87.1K |
|
2235
Editas Medicine
EDIT
$442M
| $533K | ﹤0.01% |
73,501
+6,822
| +10% | +$60.7K |
|
|
ESTE
2236
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $531K | ﹤0.01% |
40,799
+9,458
| +30% | +$127K |
|
2237
Portillo's
PTLO
$321M
| $527K | ﹤0.01% |
24,655
-3,009
| -11% | -$63.2K |
|
2238
Adecoagro
AGRO
$1.36B
| $526K | ﹤0.01% |
65,071
+10,275
| +19% | +$82.6K |
|
|
MCHB
2239
Mechanics Bancorp
MCHB
$3.68B
| $526K | ﹤0.01% |
29,219
+2,254
| +8% | +$56.6K |
|
2240
Winmark
WINA
$1.32B
| $524K | ﹤0.01% |
1,635
| – | – |
|
2241
Ducommun
DCO
$2.98B
| $524K | ﹤0.01% |
9,572
+5,069
| +113% | +$276K |
|
|
BRSP
2242
BrightSpire Capital
BRSP
$648M
| $524K | ﹤0.01% |
88,736
+10,839
| +14% | +$74.3K |
|
2243
MarineMax
HZO
$788M
| $523K | ﹤0.01% |
18,197
+3,096
| +21% | +$97.3K |
|
2244
Evolus
EOLS
$501M
| $518K | ﹤0.01% |
61,214
+5,553
| +10% | +$50.2K |
|
|
ONL
2245
Orion Office REIT
ONL
$160M
| $515K | ﹤0.01% |
76,914
-175,094
| -69% | -$1.42M |
|
|
MORF
2246
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $512K | ﹤0.01% |
+13,612
| New | +$502K |
|
2247
Titan International
TWI
$475M
| $512K | ﹤0.01% |
48,827
+5,457
| +13% | +$77.3K |
|
|
ACLX
2248
DELISTED
Arcellx
ACLX
| $511K | ﹤0.01% |
16,600
+2,900
| +21% | +$88K |
|
|
SLGC
2249
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $510K | ﹤0.01% |
200,001
| – | – |
|
|
INFA
2250
DELISTED
Informatica
INFA
| $509K | ﹤0.01% |
31,050
+7,993
| +35% | +$136K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.